Spectrum Pharmaceuticals, Inc.
| Nasdaq: SPPI
Spectrum Pharmaceuticals, Inc. is a biotechnology company with fully integrated commercial and drug development operations, with a primary focus in hematology and oncology. It operates through one segment: acquiring, developing and commercializing prescription drug products. The company markets two oncology drugs Zevalin and Fusilev and the company also develops and delivers treatment for cancer. It seeks to leverage its extensive contacts in the pharmaceutical and scientific communities to identify potentially important drug candidates that require further clinical development. Spectrum Pharmaceuticals was founded in December 1987 and is Henderson, NV.